Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

*Product:*	Alyftrek 10/50/125
Active Ingredients:	Deutivacaftor 125mg Tezacaftor 50mg Vanzacaftor calcium 10.6mg equivalent to vanzacaftor 10mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Patheon Pharmaceuticals Inc, Ohio, United States of America

*Product:*	Alyftrek 4/20/50
Active Ingredients:	Deutivacaftor 50mg Tezacaftor 20mg Vanzacaftor calcium 4.24mg equivalent to vanzacaftor 4mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Patheon Pharmaceuticals Inc, Ohio, United States of America

*Product:*	Posaconazole Devatis
Active Ingredient:	Posaconazole 100mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	Devatis Limited
Manufacturer:	Deva Holding AS, Tekirdag, Turkey

Dated this 10th day of October 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule